Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Market Cap	382.18M +3.3%
Revenue (ttm)	2.32B -26.1%
Net Income	38.78M -17.1%
EPS	0.02 -15.0%
Shares Out	2.03B
PE Ratio	9.94
Forward PE	n/a
Dividend	0.00 (1.06%)
Ex-Dividend Date	May 19, 2026

Volume	480,000
Average Volume	212,200
Open	0.1880
Previous Close	0.1780
Day's Range	0.1880 - 0.1990
52-Week Range	0.1500 - 0.2800
Beta	1.22
RSI	57.11
Earnings Date	Mar 26, 2026

About HKG:6833

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2011
• Employees: 268
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6833

Financial Performance

In 2025, HKG:6833's revenue was 2.08 billion, a decrease of -26.11% compared to the previous year's 2.82 billion. Earnings were 34.85 million, a decrease of -17.11%.

Financial numbers in CNY